Castle Biosciences (CSTL)
US Market

Castle Biosciences (CSTL) Financial Statements


Castle Biosciences Financial Overview

Castle Biosciences's market cap is currently ―. The company's EPS TTM is $-2.055; its P/E ratio is -12.91; Castle Biosciences is scheduled to report earnings on March 14, 2023, and the estimated EPS forecast is $-0.84. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement
Total Revenue$ 37.01M$ 34.84M$ 26.85M$ 25.04M$ 23.48M
Gross Profit$ 28.15M$ 27.15M$ 20.91M$ 20.44M$ 18.98M
EBIT$ -20.24M$ -3.60M$ -24.49M$ -15.15M$ -11.79M
EBITDA$ -17.32M$ -973.00K$ -22.34M$ -13.70M$ -10.70M
Net Income Common Stockholders$ -20.25M$ -1.65M$ -24.62M$ -6.43M$ -11.79M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 265.98M$ 273.17M$ 309.02M$ 329.63M$ 363.18M
Total Assets$ 457.81M$ 458.38M$ 444.43M$ 462.57M$ 433.69M
Total Debt$ 13.44M$ 7.69M$ 7.91M$ 8.08M$ 0.00
Net Debt$ -252.55M$ -265.48M$ -301.11M$ -321.55M$ -363.18M
Total Liabilities$ 46.38M$ 36.72M$ 47.09M$ 50.83M$ 21.98M
Stockholders Equity$ 411.43M$ 421.66M$ 397.34M$ 411.74M$ 411.71M
Cash Flow
Free Cash Flow$ -7.26M$ -10.41M$ -21.83M$ -3.67M$ -7.06M
Operating Cash Flow$ -5.22M$ -9.00M$ -21.43M$ -2.78M$ -6.13M
Investing Cash Flow$ -134.15M$ -27.51M$ -402.00K$ -30.89M$ -923.00K
Financing Cash Flow$ 388.00K$ 661.00K$ 1.22M$ 126.00K$ 1.89M
Currency in USD

Castle Biosciences Earnings and Revenue History

Castle Biosciences Debt to Assets

Castle Biosciences Cash Flow

Castle Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis